Posts Tagged ‘GSK’
RTP Wrapup 2/26
Friday, February 26, 2010, 12:22 amA Senate committee report blasts GlaxoSmithKline for being more concerned about the sales of Avandia than about possible serious cardiovascular risks associated with the blockbuster diabetes pill. Also, two Research Triangle area companies developing new drugs sign deals.
RTP Wrapup 2/5
Friday, February 5, 2010, 12:13 amGlaxoSmithKline wants to scale back research and development and the cuts could affect jobs at the British drugmaker’s U.S. headquarters in Research Triangle Park, IBM unveils the $360 million cloud computing center it established on its RTP campus and a Durham startup reels in $10.5 million in venture capital and a deal with Burlington-based medical testing giant LabCorp. Read more…
RTP Wrapup 11/6
Thursday, November 5, 2009, 5:40 pmQuintiles Transnational scores drug research contracts that cover whole development areas, Stiefel Laboratories shutters operations in Florida and Georgia and consolidates efforts in Research Triangle Park and a symposium organized by RTI International exposes research gaps.
RTP Wrapup 10/16
Thursday, October 15, 2009, 2:40 pmGlaxoSmithKline gets hit with a $2.5 million jury verdict, Talecris borrows $550 million two weeks after going public and Affiliated Computer Services plans to hire 150 at its call center in Raleigh.
RTP Wrapup 9/25
Thursday, September 24, 2009, 4:48 pmMicell Technologies receives $15 million from St. Jude Medical, GlaxoSmithKline curbs its funding educational programs that bring doctors up-to-date, Duke Genome Center gets a $19.5 million grant and a consortium of area universities and nonprofit organizations are chasing a piece of the $63 billion the Obama Administration wants to spend over the next six years on global health care programs.
RTP Wrapup 9/18
Thursday, September 17, 2009, 7:13 pmSalix Pharmaceuticals watches its stock soar and Pozen takes action to broaden the scope of the company while GlaxoSmithKline waits for regulatory approval of two vaccines.
RTP Wrapup 9/11
Thursday, September 10, 2009, 9:39 pmGlaxoSmithKline gets good news on its Cervarix vaccine and bad news on its blockbuster asthma treatment Advair, the N.C. Biotechnology Center prepares to build a $10.4 million expansion with the help of private donations and Quintiles Transnational gets ready for Clinical Research Education Day at N.C. Central University.
RTP Wrapup 8/28
Thursday, August 27, 2009, 6:27 pmDuke University Health System announced plans for a $700 million cancer center, GlaxoSmithKline’s diet pill Alli is being investigated for possibly causing serious liver damage and Wall Street observers project a flurry of companies may try to go public after Labor Day.
